- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 95,440 | 30.07.24 10:24:45 | -0,960 | -1,00% | 0,000 | 0,000 | 95,900 | 96,400 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 990,200 | 30.07.24 08:18:13 | -6,000 | -0,60% | 0,000 | 0,000 | 990,200 | 996,200 |
